enzalutamide

Cancer drug costs nearly $200K
Opinion, Сolumns
Feb 21, 2025
Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients ...
Read More...
Local & Social